Fmoc-L-isoleucine N-carboxyanhydride

Fmoc-L-isoleucine N-carboxyanhydride is an N-carboxyanhydride (NCA) derivative of the L-isoleucine amino acid in which the α-amino group is incorporated into the cyclic anhydride, and the α-carboxyl functionality is masked within the NCA ring while the side chain retains the isoleucine sec-butyl group. The molecule bears an Fmoc protecting group on the nitrogen of the NCA, providing an aromatic base-labile protecting group, and it contains the characteristic reactive NCA carbonyls that can undergo ring-opening to generate peptide-bond-forming intermediates while maintaining the isoleucine side-chain stereochemical identity associated with L-isoleucine. As an NCA monomer, it is used in step-growth peptide synthesis and related peptide-material preparations where controlled conversion of the NCA to growing peptide chains is required, and the Fmoc functionality supports subsequent protection/deprotection workflows in peptide assembly strategies.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.

CAT No: CP01219

Custom Peptide Synthesis
cGMP Peptide
  • Registration of APIs
  • CMC information required for an IND
  • IND and NDA support
  • Drug master files (DMF) filing
M.W/Mr.
379.4

Fmoc-L-isoleucine N-carboxyanhydride is an activated N-carboxyanhydride (NCA) derived from the L-isoleucine amino acid, bearing an Fmoc-protected amino group and an isoleucine side chain with a branched aliphatic stereocenter. The NCA functionality converts the amino acid into a highly reactive electrophile for amide bond formation, while the Fmoc group provides a base-labile protecting strategy compatible with standard peptide synthesis workflows. The chiral center of L-isoleucine is preserved through the activation step, enabling stereochemically defined incorporation into growing peptide chains. The resulting reactivity profile supports controlled polymerization or peptide coupling under peptide chemistry conditions, and the Fmoc handle enables downstream orthogonal deprotection and fragment assembly.

1. Fmoc Peptide Synthesis

Fmoc-L-isoleucine N-carboxyanhydride is applied in Fmoc-based peptide synthesis where NCA activation supports efficient peptide bond formation to introduce L-isoleucine residues with stereochemical fidelity. The Fmoc-protected amino group provides a protected N-terminus that can be removed under base to regenerate an anion-stabilized coupling site for sequential chain growth. The branched hydrophobic side chain of isoleucine participates in the formation of peptide secondary structure motifs and can influence solubility and aggregation behavior of the target sequence. The NCA format enables peptide building block preparation for both manual coupling and automated synthesis strategies, supporting the construction of defined peptide standards and research-grade peptide libraries.

2. Unnatural Amino Acid Incorporation

Fmoc-L-isoleucine N-carboxyanhydride serves as a chiral amino acid derivative for incorporation into sequences that require precise side-chain identity and stereochemical control at the residue level. The preserved L-configuration and the Fmoc-protected backbone nitrogen allow the isoleucine residue to be introduced as a defined monomer in peptide and peptidomimetic construction. The NCA electrophile can be employed to drive amide formation with nucleophilic acceptors, enabling the assembly of modified peptides used in chemical biology studies and structure-activity relationship investigations. The Fmoc deprotection compatibility further supports orthogonal intermediate handling, facilitating stepwise synthesis of analogs where residue placement and side-chain topology are critical.

3. Peptidomimetic And SAR Studies

Fmoc-L-isoleucine N-carboxyanhydride is utilized in peptidomimetic and SAR-focused synthesis where hydrophobic isoleucine side chains help tune conformational preferences and binding-site complementarity. The NCA activation supports rapid generation of amide-linked fragments that can be converted into longer scaffolds, including cyclic or constrained analogs after subsequent functional group transformations. The Fmoc group enables controlled N-terminal management during fragment coupling, supporting iterative synthesis of residue-substituted series for SAR studies. Downstream, the resulting peptide analogs can be used as chemically defined tools for mapping structure-function relationships, including conformational probes and sequence-variant comparison materials in biochemical research.

4. Polymer And Block Copolymer Design

Fmoc-L-isoleucine N-carboxyanhydride can be applied to polymer chemistry where NCA monomers participate in controlled amide-forming polymerization to generate polypeptide-like backbones bearing Fmoc-protected functionalities. The isoleucine side chain provides hydrophobic character that can be leveraged to tune polymer solubility, aggregation tendencies, and microphase separation in block architectures. The Fmoc group allows post-synthetic deprotection to expose amine functionalities for further derivatization, crosslinking, or conjugation chemistry. The resulting amino acid-based polymers and block copolymers serve as materials for functional coatings, responsive assemblies, and chemically addressable macromolecular scaffolds relevant to industrial specialty chemical development.

5. Pharmaceutical Intermediate Preparation

Fmoc-L-isoleucine N-carboxyanhydride is suitable for pharmaceutical intermediate preparation where protected amino acid derivatives and peptide-like intermediates are assembled as defined building blocks for downstream synthesis. The Fmoc-protected nitrogen provides a robust protecting-group strategy for handling reactive intermediates while maintaining compatibility with standard deprotection and coupling steps used in fine chemical manufacturing. The NCA activation supports conversion into amide-linked intermediates that can be further transformed into protected peptide fragments, peptidomimetic precursors, or chiral amide motifs. The stereochemically defined isoleucine residue supports consistent impurity profiles and reproducible scaffold construction for process chemistry routes that require controlled chiral incorporation.

6. Analytical Standards And Method Development

Fmoc-L-isoleucine N-carboxyanhydride is employed in analytical research and method development to generate defined peptide standards and calibration materials containing an L-isoleucine residue. The Fmoc handle enables systematic construction of peptide sequences with controlled N-terminal protection states, supporting reproducible sample preparation for chromatographic and mass spectrometric characterization. The NCA functionality facilitates preparation of peptide fragments with known connectivity, aiding impurity mapping, identity confirmation, and stability assessment of peptide intermediates. The resulting characterized peptide materials can then be used to support quality-by-design workflows in peptide chemistry and to validate analytical methods used across amino acid derivative manufacturing.

Abbr
Fmoc-lle-NCA

Useful Tools

Peptide Calculator

Abbreviation List

Peptide Glossary

If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.

Featured Services
Peptide CDMOPeptide Analysis ServicesCustom Conjugation ServicePeptide Modification ServicescGMP Peptide ServiceEpitope Mapping ServicesPeptide Nucleic Acids SynthesisPeptide Synthesis Services
Hot Products
About us

Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.

From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.

Our Customers